BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 20660613)

  • 1. Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.
    Zhang S; Rozell M; Verma RK; Albu DI; Califano D; VanValkenburgh J; Merchant A; Rangel-Moreno J; Randall TD; Jenkins NA; Copeland NG; Liu P; Avram D
    J Exp Med; 2010 Aug; 207(8):1687-99. PubMed ID: 20660613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
    Wang B; Maile R; Greenwood R; Collins EJ; Frelinger JA
    J Immunol; 2000 Feb; 164(3):1216-22. PubMed ID: 10640733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic role of FoxO3a in the development of CD8+ T cell memory.
    Tzelepis F; Joseph J; Haddad EK; Maclean S; Dudani R; Agenes F; Peng SL; Sekaly RP; Sad S
    J Immunol; 2013 Feb; 190(3):1066-75. PubMed ID: 23277488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-associated alterations in CD8α+ dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium.
    Li G; Smithey MJ; Rudd BD; Nikolich-Žugich J
    Aging Cell; 2012 Dec; 11(6):968-77. PubMed ID: 22862959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
    Thompson ED; Enriquez HL; Fu YX; Engelhard VH
    J Exp Med; 2010 Aug; 207(8):1791-804. PubMed ID: 20660615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid.
    Fleissner D; Frede A; Knott M; Knuschke T; Geffers R; Hansen W; Dobos G; Langhorst J; Buer J; Westendorf AM
    Immunology; 2011 Sep; 134(1):82-92. PubMed ID: 21711349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive immunity and enhanced CD8+ T cell response to Listeria monocytogenes in the absence of perforin and IFN-gamma.
    Badovinac VP; Harty JT
    J Immunol; 2000 Jun; 164(12):6444-52. PubMed ID: 10843700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gads regulates the expansion phase of CD8+ T cell-mediated immunity.
    Zhang EY; Parker BL; Yankee TM
    J Immunol; 2011 Apr; 186(8):4579-89. PubMed ID: 21411729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells.
    Jabbari A; Harty JT
    J Immunol Methods; 2006 Jun; 313(1-2):161-8. PubMed ID: 16762359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.
    Drake DR; Ream RM; Lawrence CW; Braciale TJ
    J Immunol; 2005 Aug; 175(3):1507-15. PubMed ID: 16034088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal and splenic T cell responses to enteric Listeria monocytogenes infection: distinct repertoires of responding CD8 T lymphocytes.
    Huleatt JW; Pilip I; Kerksiek K; Pamer EG
    J Immunol; 2001 Mar; 166(6):4065-73. PubMed ID: 11238655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of IL-7 receptor alpha does not support increased expansion or prevent contraction of antigen-specific CD4 or CD8 T cells following Listeria monocytogenes infection.
    Haring JS; Jing X; Bollenbacher-Reilley J; Xue HH; Leonard WJ; Harty JT
    J Immunol; 2008 Mar; 180(5):2855-62. PubMed ID: 18292507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient anti-listerial immunity in the absence of perforin can be restored by increasing memory CD8+ T cell numbers.
    Messingham KA; Badovinac VP; Harty JT
    J Immunol; 2003 Oct; 171(8):4254-62. PubMed ID: 14530349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.
    Hirose S; Touma M; Go R; Katsuragi Y; Sakuraba Y; Gondo Y; Abe M; Sakimura K; Mishima Y; Kominami R
    Int Immunol; 2015 Apr; 27(4):205-15. PubMed ID: 25422283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.
    Wooldridge L; Clement M; Lissina A; Edwards ES; Ladell K; Ekeruche J; Hewitt RE; Laugel B; Gostick E; Cole DK; Debets R; Berrevoets C; Miles JJ; Burrows SR; Price DA; Sewell AK
    J Immunol; 2010 Apr; 184(7):3357-66. PubMed ID: 20190139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.